Laparoscopic surgery has widely spread in the treatment of colorectal cancer. In Japan, a nation-wide survey has shown that a rate of advanced colorectal cancer has increased gradually and reached 65% of the total cases for colorectal cancer in 2007. For colon cancer, many randomized controlled trials regarding short-term outcome demonstrate that laparoscopic surgery is feasible, safe and has many benefits including reduction in a peri-operative mortality. In terms of long-term outcome, four randomized controlled trials insist that there are no differences in both laparoscopic and open surgeries. However, there are still more important issues including long-term oncological outcome for advanced colon cancer, cost effectiveness and the impact on quality of life of patients. Meanwhile, for rectal cancer, a controversy persists with regard to the appropriateness of laparoscopic surgery because of concerns over the safety of the procedure and a necessity of lateral lymph node dissection for lower rectal cancer. At present, laparoscopic surgery is acceptable for Stage I colon cancer, whereas there are controversies for Stage II/III colon cancer and each staged rectal cancer because of inadequate clinical evidences. Whether laparoscopic surgery further spreads to be applied for colorectal cancer or not, it would be confirmed by Japanese large-scale phase III trial (JCOG0404) estimating oncological outcome for Stage II/III colon cancer and a Phase II trial estimating the feasibility for Stage 0/I rectal cancer in near future.
INTRODUCTION
Recently, colorectal cancer has been a significant leading cause of death from malignancies in Japan as one of the western countries. Surgery is the mainstay of the treatment, with or without chemotherapy and/or radiotherapy. About 90 -92% and 84% of patients with cancer of colon and rectum, respectively, are treated surgically (1 -3) . Conventional open surgery is associated with significant morbidity and long convalescence. Laparoscopic surgery has been widely used as a minimally invasive surgery to treat diverse benign diseases such as benign gall bladder disease (4, 5) . Jacobs et al. (6) first reported the technical feasibility of laparoscopic colectomy in 1991. Since then, laparoscopic surgery has been widely operated for various benign colorectal conditions such as polyps (7), diverticular disease (8) , inflammatory bowel disease (9) , rectal prolapse (5) and now colorectal cancer increasingly.
The benefits of laparoscopic surgery in comparison with open surgery have been suggested with respect to decreased morbidity, decreased pain, faster recovery, shorter hospital stay and possibly reduced immunosuppression (10 -12) . Laparoscopic colorectal surgery is technically complex as it involves laparoscopic mobilization of colon over a wide area, intracorporeal division of major vessels, extraction of specimen and a bowel anastomosis. There is a steep learning curve to achieve advanced laparoscopic skills, and specialized equipment is required (13) . There are concerns with oncological outcome and safety of the laparoscopic procedure in colorectal cancer. There are also controversies with potential port site recurrence (14 -16) after curative resection of tumor, hospital cost (17) and the lack of data on long-term oncological outcome.
To address these concerns, several prospective randomized clinical trials have been undertaken with longer follow-up time and larger sample size (18 -22) . In Japan, a retrospective multicenter study was performed to analyze the clinical outcomes for patients with colorectal cancer (23) , and a prospective randomized controlled trial (Phase III) for advanced colon cancer (24) and a prospective feasible study (Phase II) for rectal cancer (25) have been conducted.
In this article, we have reviewed clinical studies of laparoscopic surgery versus open surgery for colorectal cancer. We have addressed the important problem whether laparoscopic surgery is acceptable or not for patients with colorectal cancer.
NATION-WIDE SURVEY OF LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER IN JAPAN
In Japan, laparoscopic surgery for colorectal cancer was introduced in 1992. The Education Committee of Japan Society of Endoscopic Surgery (JSES) conducts a nationwide survey every 2 years. Until the end of 2007, over 43 000 patients underwent laparoscopic colorectal surgery, and for the year 2007, 9000 operations were carried out in Japan (26) . A rate of advanced colorectal cancer has been increased gradually. Particularly, in 2007, 65% of the total cases were advanced cancer ( Figure 1 ). 
RETROSPECTIVE MULTICENTER STUDY OF LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER IN JAPAN

CLINICAL EVIDENCES OF LAPAROSCOPIC VERSUS OPEN SURGERY FOR COLON CANCER
As searching for all published randomized controlled trials to compare laparoscopic surgery with open surgery for colon cancer, 13 studies were demonstrated in English from 1991 to 2007 (Table 1) (18,19,21,22,28 -36) . The rate of conversion to open surgery varied widely (0 -46.4%) between those studies. There were no significant differences in overall and surgical complication rate, anastomotic leakage rate, re-operation rate and oncological clearance. However, laparoscopic surgery has a significantly lower preoperative mortality, lower wound complications, less blood loss, Figure 1 . Current status of laparoscopic surgery for colorectal cancer in Japan. A nation-wide survey in 1373 institutes of Japan was conducted by Japan Society of Endoscopic Surgery.
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Clinical evidences of laparoscopic versus open surgery for colorectal cancer reduced post-operative pain scores and reduced requirements for narcotic analgesia. After laparoscopic surgery, patients passed flatus earlier and had bowel movement earlier and resumed oral diet sooner than the patients did in open surgery. Prospective randomized controlled trials show that laparoscopic surgery for colon cancer is feasible, safe and has many short-term benefits. Four randomized controlled trials have been reported to clarify long-term outcome of laparoscopic surgery for colon cancer (Table 2) (18 -22) . These trials were evaluated in the survival, mortality and recurrence of disease associated with two types of surgical procedures with follow-up period of 3.6 -5 years. These trials reported an overall mortality rate of 17.9 -32% for laparoscopic surgery and 22. (38) . Prospective randomized controlled trials and meta-analysis in terms of long-term outcome states that there are no differences in the two surgical procedures. However, these randomized controlled trials in western countries also have several problems such as the criteria including early staged cancer and benign disease, undetermined level of lymph node dissection, unclear indication for adjuvant chemoradiotherapy and no description of quality control of the two surgical procedures.
CLINICAL EVIDENCES OF LAPAROSCOPIC VERSUS OPEN SURGERY FOR RECTAL CANCER
The results of multicenter randomized controlled trial to evaluate laparoscopic versus open surgery for rectal cancer have seldom been reported either in Japan or any other foreign countries, yet there is a report to present the fact that there is no significant difference between laparoscopic and open surgery in oncological short-term prognosis (22) . There are not many reports regarding prognosis of laparoscopic surgery for advanced rectal cancer. However, there are some reports that an incidence of complications such as anastomotic leakage and pelvic abscess in laparoscopic surgery is the same as, or higher than that in open surgery (39 -42) . In 2007, CLASICC trial group targeted 794 patients with colon and rectal cancer in multicenter randomized clinical trial of laparoscopic versus open surgery (22) . There was no significant difference in 3-years' local recurrence and overall survival rates after curative resection between both the groups. Though there was 5% in mortality rate in each group, a positive rate of circumferential resection margin in laparoscopic group was higher than that in open group. Short-term results of laparoscopic surgery for rectal cancer were shown in Table 3 ( 43 -47) . In retrospective studies, tumors were located at 0 -15 cm away from the anal verge, and a conversion rate to open surgery was 3 -12%. A rate of postoperative complications was 21 -36%, and a rate of anastomotic leakage was 5.8 -17.3%. In these reports from western countries, pre-or post-operative chemoradiotherapy was treated for 40% of patients with T3 or deeper rectal cancer. Because a standard treatment for advanced rectal cancer is different from the one in Japan, further detailed study would surely be required about the adaptation of laparoscopic surgery. or deeper colorectal cancer. Surgeons at 27 specialized institutions will recruit 1050 patients. The primary endpoint is the overall survival rate. Secondary endpoints are relapse-free survival rate, short-term clinical outcomes, adverse events and a rate of conversion from laparoscopic surgery to open surgery. The short-term clinical outcomes are the proportion of the use of analgesics, the duration from operation to flatus, the highest body temperature during hospitalization and the highest body temperature during 3 days after operation. In both arms, resection of colon or rectum with D3 lymphadenectomy is performed according to the Japanese Classification of Colorectal Carcinoma (48) . The patients are randomized by the minimization method of balancing the groups according to the location of the tumor and the institution (Figure 3 ). This Japanese randomized controlled trial has characteristic designs comparing with other western trials such as inclusion criteria of only advanced cancer (T3, T4), lymph node dissection, adjuvant chemotherapy and the quality control. In the case of pathological Stage III colorectal carcinoma, three cycles of adjuvant chemotherapy with fluorouracil and L-leucovorin are administered. To control the quality of operation, central review of surgical procedure was done by using photographs of all patients. A registration of the patients in this trial will be accomplished in March 2009.
A PROSPECTIVE STUDY FOR RECTAL CANCER IN JAPAN
To examine technical and oncological feasibility of laparoscopic surgery for rectal cancer, a Phase II trial (Lap-RC) started to be applied to patients with a preoperative diagnosis of Stage 0/I rectal cancer under the direction of the Japan Society of Laparoscopic Colorectal Surgery (26) . Surgeons at 39 specialized institutions will recruit 350 patients. The primary endpoint at the first stage is an anastomotic leakage rate by double-stapling technique and the one at the second stage is an overall survival rate. Secondary endpoints are relapse-free survival rate, short-term clinical outcome, adverse events, the rate of histologically curative operation, the proportion of completion of laparoscopic and the conversion rate. To control the quality of operation, central review of surgical procedure was done by using photographs of all patients.
CONCLUSIONS AND PERSPECTIVES
Laparoscopic surgery has widely spread as a less invasive procedure for colorectal cancer in Japan and western countries. A nation-wide survey by JSES revealed that a rate of advanced colorectal cancer has increased gradually and reached two-thirds of total cases in 2007. Many randomized controlled trials demonstrate that laparoscopic surgery for colon cancer is feasible, safe and has many short-term benefits including reduction in peri-operative mortality.
There are still more important issues including long-term oncological outcome for advanced colon cancer, costeffectiveness and the impact on quality of life of patients with colon cancer. Meanwhile, a controversy persists with regard to the appropriateness of laparoscopic surgery for patients with rectal cancer because of concerns over the safety of the procedure, especially in low anterior resections for lower rectal carcinoma. Additionally, lateral lymph node dissection combined with total mesorectal excision remains the standard surgical procedure for patients with advanced 
